Home
JNJ
JNJ News

Latest Johnson & Johnson (JNJ) News on February 23, 2025

Is Johnson & Johnson's (NYSE:JNJ) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Simply Wall St.

a day ago

Is Johnson & Johnson's (NYSE:JNJ) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Morningstar Research

a day ago

Analyst Report: Johnson & Johnson

Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?

Zacks

2 days ago

Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?

Is Johnson & Johnson (JNJ) the Best Non-Tech Stock to Buy Now for Long Term?

Insider Monkey

2 days ago

Is Johnson & Johnson (JNJ) the Best Non-Tech Stock to Buy Now for Long Term?

MT Newswires

2 days ago

Johnson & Johnson's Subcutaneous Ulcerative Colitis Treatment Shows 'Significant' Improvements

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis

PR Newswire

2 days ago

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis

Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income

Motley Fool

2 days ago

Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income

Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why

Zacks

3 days ago

Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why

Carlsberg, Johnson & Johnson Tap Europe Market for M&A Bonds

Bloomberg

4 days ago

Carlsberg, Johnson & Johnson Tap Europe Market for M&A Bonds

MT Newswires

4 days ago

Johnson & Johnson's Varipulse Device Remains 'Important Growth Driver' for Company, RBC Says

Thomson Reuters StreetEvents

4 days ago

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Argus Research

4 days ago

Technical Assessment: Bullish in the Intermediate-Term

Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value

GuruFocus.com

4 days ago

Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value

Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan

The Wall Street Journal

4 days ago

Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan

Thames Water’s Crucial Rescue Loan Approved by UK Judge

Bloomberg

5 days ago

Thames Water’s Crucial Rescue Loan Approved by UK Judge

J&J begins crucial battle over $10 billion baby powder settlement

Reuters

5 days ago

J&J begins crucial battle over $10 billion baby powder settlement

Johnson & Johnson (NYSE:JNJ) is a favorite amongst institutional investors who own 73%

Simply Wall St.

5 days ago

Johnson & Johnson (NYSE:JNJ) is a favorite amongst institutional investors who own 73%

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

6 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

J&J Stock Up More Than 6% in a Month: Time to Buy, Sell or Hold?

Zacks

6 days ago

J&J Stock Up More Than 6% in a Month: Time to Buy, Sell or Hold?

Johnson & Johnson to resume market release of Varipulse catheter in US

Medical Device Network

6 days ago

Johnson & Johnson to resume market release of Varipulse catheter in US

Why Johnson & Johnson (JNJ) Is One of the Best Drug Stocks to Buy Now

Insider Monkey

6 days ago

Why Johnson & Johnson (JNJ) Is One of the Best Drug Stocks to Buy Now

Dividend Investor With $1.05 Million In Stocks And $36,600 Annual Payout Shares Portfolio – 'Could These Picks Set You Up for Life?'

Benzinga

8 days ago

Dividend Investor With $1.05 Million In Stocks And $36,600 Annual Payout Shares Portfolio – 'Could These Picks Set You Up for Life?'

Johnson & Johnson (JNJ): Among the Best Forever Stocks to Buy Right Now

Insider Monkey

8 days ago

Johnson & Johnson (JNJ): Among the Best Forever Stocks to Buy Right Now

ROKU Q4 Loss Narrower Than Expected, Revenues Increase Y/Y

Zacks

9 days ago

ROKU Q4 Loss Narrower Than Expected, Revenues Increase Y/Y

Jim Cramer on Johnson & Johnson (JNJ): ‘Too Slow Growing’

Insider Monkey

9 days ago

Jim Cramer on Johnson & Johnson (JNJ): ‘Too Slow Growing’

J&J’s High Hopes for Heart-Rhythm Device Grounded by Safety Concerns

The Wall Street Journal

9 days ago

J&J’s High Hopes for Heart-Rhythm Device Grounded by Safety Concerns

Johnson & Johnson (NYSE:JNJ) Goes Ex-Dividend Soon

Simply Wall St.

10 days ago

Johnson & Johnson (NYSE:JNJ) Goes Ex-Dividend Soon

J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results

Clinical Trials Arena

10 days ago

J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results

Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study

Benzinga

10 days ago

Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study

PR Newswire

10 days ago

New nipocalimab data published in mAbs journal details differentiated molecular design, clinical profile and potential of nipocalimab to treat IgG-driven alloantibody and autoantibody diseases

Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead

Benzinga

10 days ago

Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead

Sanofi to take $250M charge on study failure for E. coli vaccine

BioPharma Dive

10 days ago

Sanofi to take $250M charge on study failure for E. coli vaccine

Johnson & Johnson (JNJ): Jim Cramer on “The Greatest Health Care Stock of All Time”

Insider Monkey

11 days ago

Johnson & Johnson (JNJ): Jim Cramer on “The Greatest Health Care Stock of All Time”

Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy

Insider Monkey

11 days ago

Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy

Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates

Benzinga

11 days ago

Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates

MT Newswires

11 days ago

Johnson & Johnson Insider Sold Shares Worth $2,002,878, According to a Recent SEC Filing

MT Newswires

12 days ago

Market Chatter: Johnson & Johnson Seeks to Sell Stroke Care Unit for More Than $1 Billion

Financial Times

12 days ago

Johnson & Johnson puts stroke care business up for sale

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

GuruFocus.com

12 days ago

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

Are You Looking for a High-Growth Dividend Stock?

Zacks

13 days ago

Are You Looking for a High-Growth Dividend Stock?

Warren Buffett's Granddaughter Claimed He Cut Her Off And She Couldn't Afford Health Insurance: 'He Disowned My Twin Sister And Myself'

Benzinga

13 days ago

Warren Buffett's Granddaughter Claimed He Cut Her Off And She Couldn't Afford Health Insurance: 'He Disowned My Twin Sister And Myself'

Johnson & Johnson (JNJ) Among the Best Stocks to Buy for Financial Stability

Insider Monkey

14 days ago

Johnson & Johnson (JNJ) Among the Best Stocks to Buy for Financial Stability

2 Stocks to Buy if There Is a Market Crash in 2025

Motley Fool

14 days ago

2 Stocks to Buy if There Is a Market Crash in 2025

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Motley Fool

15 days ago

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks

16 days ago

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

Pharma Voice

17 days ago

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

Surging dollar spurs jump in corporate FX hedging

Reuters

17 days ago

Surging dollar spurs jump in corporate FX hedging

Steady M&A Deals to Begin 2025, Disappointing IPOs So Far

GuruFocus.com

18 days ago

Steady M&A Deals to Begin 2025, Disappointing IPOs So Far

Starboard Launches Proxy Fight at Kenvue

The Wall Street Journal

18 days ago

Starboard Launches Proxy Fight at Kenvue

This Johnson & Johnson Insider Reduced Their Stake By 37%

Simply Wall St.

18 days ago

This Johnson & Johnson Insider Reduced Their Stake By 37%

CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi

Zacks

19 days ago

CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

GuruFocus.com

19 days ago

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference

Business Wire

19 days ago

Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference

Why Johnson & Johnson (JNJ) Is One of the Best Cancer Stock to Buy According to Hedge Funds

Insider Monkey

20 days ago

Why Johnson & Johnson (JNJ) Is One of the Best Cancer Stock to Buy According to Hedge Funds

MT Newswires

20 days ago

Guggenheim Adjusts Price Target on Johnson & Johnson to $166 From $162, Maintains Neutral Rating

ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation

Pharmaceutical Technology

20 days ago

ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation

The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern

Zacks

20 days ago

The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern

Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts

Healthcare Dive

20 days ago

Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts

Is Johnson & Johnson (JNJ) the Most Promising Dividend Stock According to Hedge Funds?

Insider Monkey

21 days ago

Is Johnson & Johnson (JNJ) the Most Promising Dividend Stock According to Hedge Funds?

Is Johnson & Johnson Stock a Buy?

Motley Fool

21 days ago

Is Johnson & Johnson Stock a Buy?

Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now?

Insider Monkey

22 days ago

Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now?

Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?

Motley Fool

22 days ago

Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?

Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Motley Fool

22 days ago

Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now

Insider Monkey

22 days ago

Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Zacks

22 days ago

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

US government could seek over $1 billion from J&J for cancer treatment costs

Reuters

22 days ago

US government could seek over $1 billion from J&J for cancer treatment costs

Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates

StockStory

23 days ago

Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates

Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs

HR Dive

24 days ago

Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs

Argus Research

24 days ago

Technical Assessment: Bullish in the Intermediate-Term

Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025?

Insider Monkey

24 days ago

Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025?

Johnson & Johnson (JNJ): Is This Healthcare Stock A Good Buy?

Insider Monkey

25 days ago

Johnson & Johnson (JNJ): Is This Healthcare Stock A Good Buy?

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

25 days ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Is Johnson & Johnson (JNJ) Among Kevin O’Leary’s Stock Picks for 2025?

Insider Monkey

25 days ago

Is Johnson & Johnson (JNJ) Among Kevin O’Leary’s Stock Picks for 2025?

Argus Research

25 days ago

The Argus Min Vol Model Portfolio

4 robotic surgery trends to watch in 2025

MedTech Dive

25 days ago

4 robotic surgery trends to watch in 2025

Jim Cramer Explains Why Johnson & Johnson (JNJ) Might Be Unfairly Judged by the Market – Here’s Why

Insider Monkey

a month ago

Jim Cramer Explains Why Johnson & Johnson (JNJ) Might Be Unfairly Judged by the Market – Here’s Why

If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

a month ago

If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock

Zacks

a month ago

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock

Why Johnson & Johnson (JNJ) Surged on Monday

Insider Monkey

a month ago

Why Johnson & Johnson (JNJ) Surged on Monday

Jim Cramer Says You Should Buy Johnson & Johnson (JNJ) Dividend Stock With 3.3% Yield

Insider Monkey

a month ago

Jim Cramer Says You Should Buy Johnson & Johnson (JNJ) Dividend Stock With 3.3% Yield

Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson

GuruFocus.com

a month ago

Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson

The Day DeepSeek Turned Tech and Wall Street Upside Down

The Wall Street Journal

a month ago

The Day DeepSeek Turned Tech and Wall Street Upside Down

Jim Cramer Says Johnson & Johnson (JNJ) is ‘Still Having A Problem With China’

Insider Monkey

a month ago

Jim Cramer Says Johnson & Johnson (JNJ) is ‘Still Having A Problem With China’

MT Newswires

a month ago

Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Zacks

a month ago

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Is Johnson & Johnson (JNJ) The Best Bear Market Stock To Invest In Now?

Insider Monkey

a month ago

Is Johnson & Johnson (JNJ) The Best Bear Market Stock To Invest In Now?

Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years?

Insider Monkey

a month ago

Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years?

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

Motley Fool

a month ago

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?

Insider Monkey

a month ago

Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?

Argus Research

a month ago

Analyst Report: Johnson & Johnson

Argus Research

a month ago

Market Digest: FDX, JNJ, MKC, RF, KMI, GEV

MT Newswires

a month ago

Daiwa Adjusts Price Target on Johnson & Johnson to $150 From $170, Maintains Neutral Rating

5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025

Motley Fool

a month ago

5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025

Disasters Spawn New Businesses. The California Wildfires Will Do the Same.

Barrons.com

a month ago

Disasters Spawn New Businesses. The California Wildfires Will Do the Same.

Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?

Motley Fool

a month ago

Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

a month ago

Bernstein Adjusts Johnson & Johnson Price Target to $158 From $160, Maintains Market Perform Rating

Why Is Prem Watsa Bullish On Johnson & Johnson (JNJ) Now?

Insider Monkey

a month ago

Why Is Prem Watsa Bullish On Johnson & Johnson (JNJ) Now?

MT Newswires

a month ago

Wells Fargo Cuts Johnson & Johnson Price Target to $152 From $166, Maintains Equal Weight Rating

MT Newswires

a month ago

Stifel Nicolaus Adjusts Johnson & Johnson Price Target to $155 From $170, Maintains Hold Rating

Share on Social Networks: